{"filings":[{"id":93305,"accession_number":"0001493152-26-017819","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo receives final $600K installment of $1M equity financing; issues 1.25M units at $0.80/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received $600K on April 15, 2026 as final payment under March 13 Subscription Agreement, completing $1M total investment.","Issued 1,250,000 units at $0.80/unit; each unit = one share common + one warrant (exercise $1.10, expires 3 years).","Of total, 750,000 units issued upon $600K final installment.","Investor has option to buy up to $1.5M additional units (max 1,875,000 units) on same terms by June 15, 2026.","Proceeds to fund commercialization of lead product Spryng™, new product development, clinical trials, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104813,"accession_number":"0001493152-26-013009","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K/A","filed_at":"2026-03-27T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo raises $1M via unit offering with warrants; $1.5M option available","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Raised $1M from 1.25M units at $0.80/unit; each unit = 1 restricted common share + 1 warrant at $1.10/strike, 3-year term.","Initial $400K received March 13, 2026; remaining $600K due by April 15, 2026.","Investor has option to purchase additional $1.5M (1.875M units) on same terms, exercisable until June 15, 2026.","Approximately 35.2M common shares outstanding as of March 11, 2026; offering exempt under Reg D/accredited investors.","Proceeds for commercialization of Spryng™, new product development, clinical trials, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104818,"accession_number":"0001493152-26-010335","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo raises $1M in private placement, secures option for additional $1.5M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 1,250,000 restricted common shares and warrants at $0.80/unit for $1M; $400K received Mar 13, 2026.","Investor receives purchase option for up to 1,500,000 additional units at $0.80/unit ($1.5M) exercisable before June 15, 2026.","Each unit includes one common share and one warrant with $1.10 strike, 3-year term.","Proceeds to fund commercialization of Spryng, product development, clinical trials, and working capital.","Company has approx. 35.2M shares outstanding as of March 11, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104817,"accession_number":"0001493152-26-008745","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PetVivo Holdings files 8-K with investor presentation; no material new info disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company furnished investor presentation under Item 7.01 Regulation FD on March 3, 2026.","Presentation intended for use at investor conferences; content not included in this filing.","No new financial results, product news, or guidance provided in the 8-K itself.","Company makes no admission as to materiality of the furnished information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104816,"accession_number":"0001493152-26-004231","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Spencer Breithaupt resigns from PetVivo board; vacancy left unfilled","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Spencer Breithaupt resigned from the Board effective January 26, 2026; no disagreement with the Company.","Board size reduced from 7 to 6 directors; vacancy will not be filled at this time.","Board retains discretion to later appoint an additional director to restore size to 7.","Company expressed appreciation for Breithaupt's leadership and contributions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104815,"accession_number":"0001493152-26-003220","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2026-01-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PetVivo files 8-K to furnish investor presentation; no specific details provided","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filing filed under Item 7.01 for Regulation FD disclosure; presentation not included in text.","Exhibit 99.1 is a January 2026 investor presentation intended for investor conferences.","Company may disclose this information in whole or in part at various forums.","No financial or operational updates are ascertainable from the filing alone."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104814,"accession_number":"0001493152-26-002223","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2026-01-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"PetVivo director Michael Eldred resigns from board, vacancy left unfilled","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Eldred resigned from PetVivo's Board of Directors effective January 9, 2026; no disagreement cited.","Board size reduced from 8 to 7 directors; the vacancy will not be filled at this time.","Remaining board members continue; Mr. Eldred thanked for service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121093,"accession_number":"0001493152-25-020574","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PetVivo provides investor presentation; no specific financial data available in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company made investor presentation dated November 2025 available for conferences.","No new financial metrics, guidance, or material events disclosed in this filing.","Common stock (PETV) and warrants (PETVW) trade on OTC markets.","Presentation content not reproduced; no numbers or updates extracted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121092,"accession_number":"0001493152-25-020203","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"PetVivo expands board to eight, appoints Josh Ruben as director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased from 7 to 8; Josh Ruben appointed independent director effective October 28, 2025.","Ruben is Managing Director of Life Sciences at Trinity Capital, formerly RBC Capital Markets and Wells Fargo.","Compensation as non-employee director will be consistent with other non-employee directors, pro-rated for service.","Ruben has not been assigned to any board committees at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137721,"accession_number":"0001493152-25-016139","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-09-30T23:59:59+00:00","items":["1.02","1.01","9.01"],"status":"ready","headline":"PetVivo converts $2.02M debt into 3.67M shares via note conversion agreements","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Four shareholders converted $2,018,155 aggregate debt (principal $1.85M + interest $168,155) into 3,669,806 restricted shares.","Conversion prices ranged from $0.50 to $0.75 per share; all debt fully satisfied and notes cancelled.","Issuance exempt under Section 4(a)(2) of Securities Act; shares restricted under Rule 144 pending holding period.","Effective date September 30, 2025; lenders are accredited investors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155108,"accession_number":"0001641172-25-016271","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo receives final $1M from $5M Series B Convertible Preferred Stock offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received $1M from full exercise of Purchase Option, completing $5M equity financing.","Total of $5M raised via Series B Convertible Preferred Stock at $1 per share, convertible 1:1 into common stock.","Proceeds intended for commercialization of Spryng and PrecisePRP, clinical trials, and working capital.","Sale made under Section 4(a)(2) to accredited investor; shares are restricted.","Certificate of Designation filed on March 26, 2025; amendment on March 31, 2025 for Company Call Option."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155107,"accession_number":"0001641172-25-015708","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo receives $3M from partial exercise of Series B convertible preferred stock purchase option","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received $3,000,000 from partial exercise of Purchase Option; total proceeds to date $4,000,000 out of $5,000,000 offering.","Remaining $1,000,000 expected by June 26, 2025; shares priced at $1.00 each, convertible 1:1 to common stock.","Proceeds to fund commercialization of Spryng™ and PrecisePRP, clinical trials, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155106,"accession_number":"0001641172-25-015235","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo receives $200K from partial exercise of Series B Convertible Preferred purchase option","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received $200,000 on June 16, 2025; total $1,000,000 received under $5M Series B Preferred offering.","Remaining $4,000,000 purchase option exercisable by investor; anticipated receipt by June 26, 2025.","Series B Preferred shares priced at $1.00 each, convertible 1:1 into common stock.","Securities sold to accredited investor under Section 4(a)(2) exemption; shares are restricted.","Proceeds to fund commercialization of Spryng™ with OsteoCushion™ Technology and PrecisePRP, clinical trials, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155105,"accession_number":"0001641172-25-014760","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"PetVivo issues $160K promissory note with warrant; conversion at $0.75/share","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Note principal $160,000 at 10% annual interest, matures Dec 31, 2025.","Note convertible into up to 213,334 shares at $0.75 per share.","Lender receives warrant to purchase 75,000 shares at $0.90 per share, 2-year term.","Issued to existing shareholder; shares restricted under Section 4(a)(2)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155104,"accession_number":"0001641172-25-008992","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo receives $200K on partial option exercise; extends Series B preferred offering option to June 26","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received $200,000 on May 6, 2025 from partial exercise of Purchase Option under March 26 Subscription Agreement.","Purchase Option extended 30 days to June 26, 2025 for up to $4.2M remaining of $5M Series B Convertible Preferred offering.","Shares priced at $1.00 each; investor represented as accredited; securities unregistered and restricted.","Proceeds intended for commercialization of Spryng™, PrecisePRP, clinical trials, and working capital.","Option allows purchase of up to 4,400,000 additional shares at same terms; no minimum offering amount."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155103,"accession_number":"0001641172-25-003208","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-04-08T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"PetVivo replaces auditor after Assurance Dimensions exits public-company audit practice","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Assurance Dimensions resigned April 1, 2025, citing exit from providing audit services to public companies.","No disagreements or reportable events between PetVivo and Assurance Dimensions during FY2023, FY2024, or interim period.","Stephano Slack LLC engaged as new independent auditor effective April 7, 2025 for fiscal year ending March 31, 2025.","Prior auditor's reports on FY2023 and FY2024 financials were unqualified and contained no adverse opinions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173631,"accession_number":"0001641172-25-001429","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["1.01","3.02","5.03","9.01"],"status":"ready","headline":"PetVivo raises $5M in Series B convertible preferred stock financing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Initial $600K received; investor may purchase remaining $4.4M by May 27, 2025.","Preferred shares pay 10% annual dividend in common stock; convertible 1:1 into common.","Company can call shares after 2 years at $1.15 per share; proceeds for commercialization.","Stock trades OTCQB (PETV) after Nasdaq delisting; offering is exempt under Section 4(a)(2).","Use of proceeds: lead products Spryng and PrecisePRP, clinical trials, working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173622,"accession_number":"0001641172-25-001616","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K/A","filed_at":"2025-03-31T23:59:59+00:00","items":["1.01","3.02","5.03","9.01"],"status":"ready","headline":"PetVivo raises $5M via Series B Convertible Preferred Stock; initial $600K funded","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["$5M Series B Convertible Preferred offering at $1.00/share; $600K initial, option for additional $4.4M.","Preferred stock carries 10% annual dividend payable in common stock; shares convertible 1:1 into common.","Company call option after 2 years at $1.15/share; holder may convert during 30-day call period.","Proceeds for commercialization of Spryng™ and PrecisePRP, clinical trials, and working capital.","Filed Certificate of Designation for Series B Preferred with Nevada Secretary of State."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173630,"accession_number":"0001641172-25-000658","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-03-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"PetVivo extends CEO term to 2027, cuts base salary to $150K","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Term extended to March 31, 2027; base salary set at $150,000 per year, retroactive to May 1, 2024.","Bi-monthly payments of $6,250; prior salary not disclosed but filing states a reduction.","Board approved amendment March 25, 2025; parties to negotiate replacement compensation for the reduction.","CEO John Lai continues; amendment reflects cost-cutting measures for the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173629,"accession_number":"0001493152-25-009657","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"PetVivo borrows $200K from director Michael Eldred at 12% interest; issues 100K-share warrant","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal $200,000, 12% annual interest, maturity on or about September 3, 2025.","Lender received warrant to purchase 100,000 shares at $0.50/share with two-year term.","Note secured by first-priority security interest in accounts receivable from Vedco and Clipper Distributing.","Transaction is with a related party (board member Michael Eldred).","Prepayment allowed without penalty; warrants are additional compensation for the loan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173628,"accession_number":"0001493152-25-008632","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"PetVivo Holdings subsidiary PetVivo, Inc. renamed to PetVivo Animal Health, Inc. effective March 1, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective March 1, 2025, subsidiary PetVivo, Inc. renamed to PetVivo Animal Health, Inc.","Amendment acknowledged by Minnesota Secretary of State on February 11, 2025; press release issued February 27, 2025.","Bylaws amended and restated to reflect new name; parent company PetVivo Holdings, Inc. unchanged.","Parent company's common stock (PETV) and warrants (PETVW) trading on OTCQB and OTCPINK remain unaffected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173627,"accession_number":"0001493152-25-007121","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"PetVivo raises $500K via convertible notes at 10% interest to fund VetStem license","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Two existing shareholders lend $300K and $200K, maturing Feb 14, 2026.","Interest at 10% per annum; conversion price $0.65 per share; up to ~846K shares issuable.","Warrants for 150K and 100K shares at $0.90 exercise price, 3-year term.","Proceeds used for initial payment under License Agreement with VetStem, Inc.","10% of monthly Net Sales from PrecisePRP products applied to reduce principal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173626,"accession_number":"0001493152-25-007118","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"PetVivo signs exclusive license for VetStem's PrecisePRP canine and equine products","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Upfront license fee of $500,000; milestone payments up to $500,000 in $250,000 increments.","PetVivo issues 1M shares valued at $1.0M and warrant for 250K shares at $1.25 exercise price.","Royalties based on net sales; term expires later of 10 years after first commercial sale or last valid claim.","Product is an off-the-shelf allogeneic freeze-dried PRP with consistent 4B platelets per vial; no blood draw required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173625,"accession_number":"0001493152-25-006395","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-02-13T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo raises $617,500 in private placement of 950,000 shares at $0.65/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 950,000 restricted common shares at $0.65 each to ~8 accredited investors.","Net proceeds to fund commercialization of Spryng™ with OsteoCushion™ Technology and clinical trials.","Approximately 20.6M common shares and 3.0M series A preferred shares outstanding as of Jan 5, 2025.","Shares sold under Section 4(a)(2) exemption; bear Rule 144 restrictive legend."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173624,"accession_number":"0001493152-25-004803","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"PetVivo eliminates COO role, terminates employment of Randall A. Meyer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Position of Chief Operating Officer eliminated effective January 31, 2025 as part of cost-cutting initiatives.","Randall A. Meyer, COO since November 10, 2021, terminated immediately.","Responsibilities reassigned to Josh Wilhelm, Zach Swanson, Dave Heller, and Jeremy Kaplan.","Company thanks Mr. Meyer for his past service and wishes him well."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173623,"accession_number":"0001493152-25-000086","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2025-01-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PetVivo furnishes January 2025 investor presentation; no material new details disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed under Item 7.01 for Regulation FD; presentation intended for investor conferences.","No specific financial results, milestones, or guidance changes were included in the filing text.","Investor presentation content was not reproduced in the available exhibit excerpt.","Company common stock (PETV) and warrants (PETVW) trade on OTCQB."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190597,"accession_number":"0001493152-24-052142","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-12-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PetVivo Holdings files 8-K to furnish investor presentation; no material new information identified","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnishes December 2024 investor presentation under Regulation FD; presentation content not provided in this analysis.","Investor presentation may include forward-looking statements; available on company website.","No specific financial or operational updates can be extracted from the filing alone."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190596,"accession_number":"0001493152-24-040705","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"PetVivo adopts non-employee director compensation policy for FY2025; aggregate cost ~$223K","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Each non-employee director receives $10,000 annual cash retainer, payable quarterly as cash flow permits.","Annual equity award of 35,000 RSUs per director, vesting quarterly in equal installments at VWAP.","Committee meeting attendance fee of $500 per meeting; chair compensation ranges from $5,000 to $10,000 annually per role.","Total estimated compensation expense for 12-month period is ~$223,000, assuming $0.55 per share for RSUs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190595,"accession_number":"0001493152-24-038960","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"PetVivo Chairman James Martin passes away on September 28, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James Martin, Chairman of the Board, died peacefully on September 28, 2024.","He served as a director since 2019 and as Chairman since 2022.","No replacement has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207092,"accession_number":"0001493152-24-038223","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-09-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"PetVivo appoints Mike Eldred to board, expanding from seven to eight directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased to eight directors, effective Sep 25, 2024; Eldred fills new seat.","Eldred served as president/CEO of Dechra Pharmaceutical's North American ops until June 2024.","At Dechra he built team to 250+ people and grew sales to £191.6 million.","Eldred is deemed independent under Exchange Act; no committee assignment yet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207091,"accession_number":"0001493152-24-035333","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"PetVivo Holdings delisted from Nasdaq; securities to trade on OTCQB","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq filed Form 25 on Sept 6, 2024 to delist PETV and PETVW due to noncompliance with Listing Rule 5550(b).","Delisting becomes effective 10 days after the Form 25 filing.","Common stock and warrants have been trading on OTCQB Market since July 29, 2024, and will continue.","Trading symbols remain PETV and PETVW on OTCQB."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207090,"accession_number":"0001493152-24-029371","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-07-29T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"PetVivo to delist from Nasdaq, begin trading on OTCQB on July 29","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq Board declined to review delisting decision on July 25, 2024; company will not appeal to SEC.","Common stock and warrants to begin trading on OTCQB Market on July 29, 2024 under symbols PETV and PETVW.","Company expects Nasdaq to file Form 25-NSE formally removing securities from listing in near future.","Securities had been suspended from Nasdaq since April 5, 2024; delisting affirmed by Hearing Panel on June 24.","PetVivo will continue to file periodic reports with SEC under Exchange Act after delisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207089,"accession_number":"0001493152-24-028063","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["1.01","3.02","5.03","9.01"],"status":"ready","headline":"PetVivo raises $1.21M via private placement of Series A Preferred and warrants at $0.40/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Raised $1,210,000 by selling 3,025,000 units at $0.40/unit to 3 accredited investors.","Each unit consists of one Series A Convertible Preferred share and one warrant exercisable at $0.90 for 3 years.","Series A Preferred converts to common at lesser of $0.40 or higher of $0.25/future offering price; auto-converts after one year.","Company's securities remain suspended from Nasdaq; delisting affirmed but not yet effective.","Proceeds to be used for commercialization of Spryng™, clinical trials, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224427,"accession_number":"0001493152-24-025639","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-06-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"PetVivo FY2024 revenue up 6% to $969K; net loss widens to $11.0M; FY2025 guidance $1.5-$2.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $969K (+6% YoY); gross margin 76.3% (+40 bps).","Net loss $11.0M ($0.78/sh) vs $8.7M ($0.85/sh) prior year; cash $87K at year-end.","Subsequent to year-end, raised $1.8M in net proceeds; guides FY2025 revenue $1.5-$2.0M.","Spryng distributed to >700 clinics, >6,000 syringes; added distributor Covetrus."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224426,"accession_number":"0001493152-24-018952","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo raises $1.1M via private placement of common stock and warrants; also converts $300K note","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company sold 1,567,857 units at $0.70 each to 10 accredited investors, raising $1,097,500.","Each unit consists of one restricted common share and one warrant exercisable at $1.50 until May 7, 2027.","Additionally, $300,000 convertible note plus $1,558 accrued interest converted into equity, raising $301,558.","Proceeds intended for commercialization of Spryng product, clinical trials, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224425,"accession_number":"0001493152-24-017304","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["1.01","1.02","9.01"],"status":"ready","headline":"PetVivo converts $300K note from 10% holder into 430,798 units (share + warrant) at $0.70/unit","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Converted $300,000 principal plus $1,558 accrued interest into 430,798 Units at $0.70/Unit.","Each Unit consists of one restricted share of common stock and one warrant to buy one share at $1.50 for three years.","A.L. Sarroff Fund LLC, a >10% shareholder, is the noteholder converting; note fully cancelled.","Issuance exempt from registration under Section 4(a)(2); shares restricted under Rule 144."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224424,"accession_number":"0001493152-24-016264","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"PetVivo COO salary cut to $150k; three execs total reduction 50.6%","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Randall Meyer salary reduced from $270,000 to $150,000, effective May 1, 2024.","Combined with CEO and CBO reductions, three execs total annual pay cut 50.6% ($850k to $420k).","Part of company-wide cost reduction program to preserve cash and lower operating loss."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224423,"accession_number":"0001493152-24-015501","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-04-22T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"PetVivo launches cost reduction program; CEO and CBDO/GC salaries cut","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO John Lai salary reduced from $350,000 to $150,000 per year, effective May 1, 2024.","Chief Business Dev. Officer John Dolan salary reduced from $230,000 to $120,000 annually.","Program led by new CFO Garry Lowenthal; additional labor and operating cuts expected.","Goal is to preserve cash, reduce operating loss and monthly cash burn."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224422,"accession_number":"0001493152-24-015357","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-04-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"PetVivo grants CEO John Lai 150,000 RSUs at $0.60/share, fully vested","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["150,000 RSUs granted to CEO John Lai at $0.60 per share, aggregate value $90,000.","RSUs fully vested on grant date April 15, 2024, under 2020 Equity Incentive Plan.","Each RSU represents right to receive one share of common stock.","Grant effective April 15, 2024; no new leadership or departure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224421,"accession_number":"0001493152-24-014735","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-04-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"PetVivo enters $300K convertible note with major shareholder at $0.70/unit","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$300K note from >10% holder A.L. Sarroff Fund; 10% interest, matures May 10, 2024.","Convertible into up to ~435,000 Units (1 restricted share + 1 warrant each); effective conversion price $0.70/Unit.","Warrants exercisable at $1.50 per share through third anniversary of issue date.","Shares upon conversion are restricted under Rule 144; note exempt under Section 4(a)(2)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224420,"accession_number":"0001493152-24-014003","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"PetVivo receives Nasdaq delisting notice; trading suspended April 9; appeals ongoing","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq Panel determined PetVivo failed to comply with $2.5M stockholders' equity rule by April 1, 2024.","Trading of PETV and PETVW suspended effective April 9, 2024; company expects OTC Markets listing.","Company filed second appeal to Nasdaq Listing Council on April 8; briefing schedule extends to May 15.","Stockholders' equity had fallen below $2.5M as of September 30, 2023, triggering original delisting notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243734,"accession_number":"0001493152-24-009946","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-03-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"PetVivo appoints Garry Lowenthal as CFO with $200k salary and 90,000 RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mr. Lowenthal appointed CFO effective March 8, 2024; base salary $200,000 paid to his holding company.","Signing bonus of $10,000 upon execution; eligible for annual performance bonuses.","Award of 90,000 RSUs: 45,000 vest Jan 28, 2025 and 45,000 vest Jan 28, 2026.","Employment agreement term through March 31, 2027; includes non-compete and non-solicitation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243733,"accession_number":"0001493152-24-009497","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"PetVivo terminates ATM sales agreement with ThinkEquity; raised $959k prior","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ATM Agreement with ThinkEquity LLC terminated effective March 7, 2024.","Agreement permitted up to $2.5M in at-the-market offerings of common stock.","Prior to termination, PetVivo sold 674,000 shares raising net proceeds of $959,033.","No reason for termination or alternative funding source disclosed in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243732,"accession_number":"0001493152-24-009019","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"PetVivo dual lists common stock on Upstream exchange for non-U.S. investors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Trading under ticker PETV on Upstream began March 5, 2024 at 10:00am EST.","Upstream is a MERJ Exchange market; only non-U.S. persons may trade on the platform.","Shares are represented as MERJ Depository Interests (MDIs), 1:1 with Nasdaq-listed common stock.","No change in shareholder rights; same CUSIP/ISIN, same class, SEC-registered shares.","Upstream offers digital-first, peer-to-peer trading with 20-hour market, 5 days a week."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243731,"accession_number":"0001493152-24-005898","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-02-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"PetVivo Q3 revenue up 17% YoY to $596K; net loss narrows to $1.75M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $595,891 vs $510,109 YoY; new Covetrus distribution contributed $106K, MWI sales $440K.","Net loss $1,749,848 ($0.12 per share) vs $2,311,618 ($0.23) prior year; gain on extinguishment of payables.","Operating loss $2,133,624 vs $2,318,818; operating expenses flat at $2.55M.","Raised $1.2M in gross proceeds from private offering after quarter end.","Added Diane Levitan, DVM, to board; signed distribution deals with Covetrus and MWV."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":920440.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243730,"accession_number":"0001493152-24-005630","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-02-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"PetVivo major shareholder converts $123,255 note into 164,340 shares at $0.75/share","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Alan Sarnoff, a >10% shareholder, converted $120,000 principal plus $3,255 accrued interest into 164,340 restricted shares at $0.75/share.","Original note (Oct 16, 2023) had $1.60 conversion price and Nov 14, 2023 maturity; amended Nov 13, 2023 to extend maturity to May 14, 2024 and lower price.","Conversion occurred on February 5, 2024, retiring the note and interest obligation.","Shares issued as restricted under Section 4(a)(2) exemption; not registered under Securities Act.","Transaction reduces debt by $123,255 and adds 164,340 shares to outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243729,"accession_number":"0001493152-24-005285","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-02-07T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PetVivo raises $1.25M in private placement of units at $0.90/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 1,386,469 units to 13 accredited investors at $0.90 per unit.","Each unit includes one restricted share and one warrant exercisable at $1.50 until Feb 1, 2027.","Proceeds to be used for commercialization of Spryng™ with OsteoCushion™ Technology, clinical trials, and working capital.","Warrants are immediately exercisable with no cashless exercise rights.","Securities are restricted under Rule 144; no registration rights."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243728,"accession_number":"0001493152-24-005178","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-02-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"PetVivo Holdings names audit, compensation and governance committee members","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Audit Committee: Robert Costantino (Chair), Joseph Jasper, James Martin (all independent).","Compensation Committee: Robert Rudelius (Chair), Robert Costantino, Spencer Breithaupt (all independent).","Nominating & Governance Committee: Joseph Jasper (Chair), Robert Rudelius, Diane Levitan (all independent)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243727,"accession_number":"0001493152-24-003755","cik":1512922,"company_name":"PetVivo Holdings, Inc.","ticker":"PETV","form_type":"8-K","filed_at":"2024-01-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"PetVivo CFO Robert Folkes resigns effective Feb 2, 2024; will assist during transition","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert J. Folkes resigns as CFO, effective February 2, 2024.","Folkes will continue providing CFO and accounting services until a new full-time CFO is hired.","Company and Folkes plan to enter a transition services agreement on or before Feb 2, 2024.","No successor CFO has been named as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28013934.92847196,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}